Biology of residual breast cancer after therapy: a kinetic interpretation.
Norton
L
L
Memorial Sloan-Kettering Cancer Institute, New York, NY 10021.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D014407:Tumor Cells, Cultured
D006133:Growth Substances